Recombinant Human IL-17A

CAT:
952-B2018307
Size:
1 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Recombinant Human IL-17A - image 1

Recombinant Human IL-17A

  • Description:

    Recombinant Human IL-17A_x000D_ Catalog number: B2018307_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 µg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Interleukin-, IL-17A_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Miller JE, Ahn SH, Marks RM, Monsanto SP, Fazleabas AT, Koti M, Tayade C. IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis Front Immunol. 2020 Feb 14;11:108._x000D_ 2: Lee JS, Tato CM, Joyce-Shaikh B, Gulen MF, Cayatte C, Chen Y, Blumenschein WM, Judo M, Ayanoglu G, McClanahan TK, Li X, Cua DJ. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability Immunity. 2015 Oct 20;43(4):727-38._x000D_ 3: Kang JH, Park S, Rho J, Hong EJ, Cho YE, Won YS, Kwon HJ. IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC Gastric Cancer. 2023 Jan;26(1):82-94._x000D_ 4: Speeckaert R, van Geel N, Lambert J, Claeys L, Delanghe JR, Speeckaert MM. Secukinumab: IL-17A inhibition to treat psoriatic arthritis Drugs Today (Barc). 2016 Nov;52(11):607-616._x000D_ 5: Li D, Wang T, Ma Q, Zhou L, Le Y, Rao Y, Jin L, Pei Y, Cheng Y, Huang C, Gai X, Sun Y. IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD Int J Chron Obstruct Pulmon Dis. 2022 Oct 14;17:2589-2602._x000D_ 6: Kwofie K, Scott M, Rodrigues R, Guerette J, Radford K, Nair P, Richards CD. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M Respir Res. 2015 Feb 7;16(1):14._x000D_ 7: Chen S, Yu L, Deng Y, Liu Y, Wang L, Li D, Yang K, Liu S, Tao A, Chen R. Early IL-17A Prevention Rather Than Late IL-17A Neutralization Attenuates Toluene Diisocyanate-Induced Mixed Granulocytic Asthma Allergy Asthma Immunol Res. 2022 Sep;14(5):528-548._x000D_ 8: Patel DD, Lee DM, Kolbinger F, Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii116-23._x000D_ 9: Ying L, Yao Y, Lv H, Lu G, Zhang Q, Yang Y, Zhou J. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway Am J Physiol Cell Physiol. 2022 May 1;322(5):C814-C824._x000D_ 10: Shah M, Maroof A, Gikas P, Mittal G, Keen R, Baeten D, Shaw S, Roberts SJ. Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells RMD Open. 2020 Jul;6(2):e001306. _x000D_ _x000D_ Products Related to Recombinant Human IL-17A can be found at Proteins
  • Short Description:

    Catalog Number: B2018307 (1 µg)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5
  • CAS Number:

    9000-83-3